BIOMAT Database Logo BIOMAT Database Logo

Antiphospholipid syndrome in patients with cyanotic congenital heart disease. 1995

M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Rheumatology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, México D.F.

Patients with cyanotic congenital heart disease exhibit an increased incidence of thrombotic episodes and are frequently thrombocytopenic. We studied the sera of 15 patients with this type of heart malformation, searching for anticardiolipin antibodies. 3/15 had positive results. The three of them were adult females; two had thrombotic episodes and a false positive VDRL. Thus, cyanotic congenital heart disease may be another disease entity associated with the antiphospholipid syndrome.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D003490 Cyanosis A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule. Cyanoses
D005260 Female Females
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016736 Antiphospholipid Syndrome The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). Anti-Phospholipid Antibody Syndrome,Anti-Phospholipid Syndrome,Antiphospholipid Antibody Syndrome,Hughes Syndrome,Anti Phospholipid Antibody Syndrome,Anti Phospholipid Syndrome,Antibody Syndrome, Anti-Phospholipid,Antibody Syndrome, Antiphospholipid,Antiphospholipid Antibody Syndromes,Syndrome, Anti-Phospholipid,Syndrome, Anti-Phospholipid Antibody,Syndrome, Antiphospholipid,Syndrome, Antiphospholipid Antibody,Syndrome, Hughes

Related Publications

M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
[Hemoptysis in patients with congenital cyanotic heart disease].
July 1997, Anales espanoles de pediatria,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Nephropathy in patients with cyanotic congenital heart disease.
June 1993, The Tokushima journal of experimental medicine,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Atherosclerosis in patients with cyanotic congenital heart disease.
July 2010, Circulation journal : official journal of the Japanese Circulation Society,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Subclinical atherosclerosis in patients with cyanotic congenital heart disease.
May 2019, International journal of cardiology,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Coagulation abnormalities in patients with cyanotic congenital heart disease.
December 2002, Journal of cardiothoracic and vascular anesthesia,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Ascites in adult patients with cyanotic congenital heart disease.
January 2011, World journal for pediatric & congenital heart surgery,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Renal involvement in patients with congenital cyanotic heart disease.
December 1991, Acta paediatrica Scandinavica,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Cerebral abscess in patients with congenital cyanotic heart disease.
December 1970, Neurology India,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Increased thrombogenesity in patients with cyanotic congenital heart disease.
June 2007, Circulation journal : official journal of the Japanese Circulation Society,
M Martínez-Lavín, and C Fonseca, and M C Amigo, and A Nava, and P A Reyes, and A Ruiz-Argüelles
Subclinical atherosclerosis in patients with cyanotic congenital heart disease.
February 2019, International journal of cardiology,
Copied contents to your clipboard!